Table 3 Association of BCVA with Baseline and clinical characteristics patients
Variable | LogMAR BCVA Mean (±SD) | P-value |
|---|---|---|
Sex | ||
 Male | 0.545 (±0.64) | 0.007* |
 Female | 0.873 (±0.84) |  |
RP associated with a syndrome | ||
 Yes | 0.667(±0.67) | 0.340℗ |
 No | 0.661 (±0.75) |  |
CME | ||
 Present | 0.33(±0.22) | < 0.001* |
 Absent | 0.73(±0.79) |  |
Ellipsoid Zone | ||
 Intact | 0.430(±0.55) |  |
 Abnormal | 0.408(±0.35) | < 0.001** |
 Absent | 1.13(±0.97) |  |
External Limiting Membrane | ||
 Intact | 0.415(±0.47) |  |
 Absent | 1.11(±0.93) | < 0.001** |
 Abnormal | 0.407(±0.39) |  |
ERM | ||
 Present | 0.402 (±0.69) | 0.125℗ |
 Absent | 0.693 (±0.6) |  |
Vitreous hyperreflective foci | ||
 Present | 0.590 (±0.66) | 0.551℗ |
 Absent | 0.684 (±0.69) |  |